Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SVA

Sinovac Biotech (SVA) Stock Price, News & Analysis

Sinovac Biotech logo

About Sinovac Biotech Stock (NASDAQ:SVA)

Advanced Chart

Key Stats

Today's Range
$6.47
$6.47
50-Day Range
$6.47
$6.47
52-Week Range
$5.73
$8.75
Volume
N/A
Average Volume
N/A
Market Capitalization
$644.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinovac Biotech and its competitors with MarketBeat's FREE daily newsletter.

SVA Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

SVA Stock Analysis - Frequently Asked Questions

Sinovac Biotech's top institutional investors include Geode Capital Management LLC (0.03%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sinovac Biotech investors own include Pfizer (PFE), Tesla (TSLA), AT&T (T), Exxon Mobil (XOM), Abbott Laboratories (ABT), Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ).

Company Calendar

Record date for 7/7 Dividend
5/23/2025
Dividend Payable
7/07/2025
Ex-Dividend for 7/7 Dividend
7/08/2025
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:SVA
CIK
1084201
Employees
3,261
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$448.27 million
Price / Sales
1.44
Cash Flow
$0.17 per share
Price / Cash Flow
38.95
Book Value
$120.83 per share
Price / Book
0.05

Miscellaneous

Outstanding Shares
99,640,000
Free Float
86,894,000
Market Cap
$644.67 million
Optionable
Optionable
Beta
0.61
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:SVA) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners